Graeme Hewitt
Graeme Hewitt
@graemehewitt.bsky.social
Reposted by Graeme Hewitt
Want to automate workflows in #FIJI?
Don't know where to start?
We (@lankylaste.bsky.social, Alicja Skórkowska and Sara Salgueiro Torres) have added a step-by-step tutorial to the wiki to get you started.

Thanks @ctrue.bsky.social for adding!

imagej.github.io/tutorials/ba...
Batch Processing with the ImageJ Macro Language
The ImageJ wiki is a community-edited knowledge base on topics relating to ImageJ, a public domain program for processing and analyzing scientific images, and its ecosystem of derivatives and variants...
imagej.github.io
October 23, 2025 at 4:32 PM
Reposted by Graeme Hewitt
New preprint from the lab! Lactate, a tumor-derived metabolite, blocks B cells from entering tumors and forming tertiary lymphoid structures (TLSs). Congratulations Victoire Boulat - in a great collaboration with Anita Grigoriadis! tinyurl.com/3vvk9kec #Immunology #TLS #CancerMetabolism #Bcells
October 6, 2025 at 4:48 PM
Reposted by Graeme Hewitt
🚀 New preprint alert!

We uncover SLFN11 as a molecular gatekeeper that restricts alternative lengthening of telomeres (ALT) by sensing telomere-associated replication stress and triggering apoptosis.

📄 Read the manuscript here: www.biorxiv.org/content/10.1...
SLFN11 restricts escape from telomere crisis to prevent alternative lengthening of telomeres
The tRNA nuclease SLFN11 is epigenetically silenced in ~50% of treatment-naive tumours and is the strongest predictor of chemoresistance but why it is frequently inactivated in cancer is unknown. To a...
www.biorxiv.org
September 11, 2025 at 7:23 AM
Reposted by Graeme Hewitt
Now peer reviewed and in its final form @natcomms.nature.com

www.nature.com/articles/s41...
July 21, 2025 at 12:59 PM
Reposted by Graeme Hewitt
Big pharma and investors are piling into the precision radiation space as the next generation of increasingly potent targeted α-particle therapies promises to destroy cancerous cells with minimum damage to healthy tissues nature.com/articles/s41...
rdcu.be/em3YY
Biopharma dives into tumor-seeking radioactive drugs - Nature Biotechnology
Big pharma and investors are piling into the precision radiation space as the next generation of increasingly potent targeted α-particle therapies promises to destroy cancerous cells with minimum dama...
nature.com
May 22, 2025 at 4:29 PM
Reposted by Graeme Hewitt
A PhD position is open in my group here in Heidelberg. We'll use cool primary cell models of osteosarcoma and genetic screens to understand and overcome mechanisms of clinically acquired drug resistance. It'll be a blast!

karriere.klinikum.uni-heidelberg.de/index.php?ac...
PhD position in the biology and treatment of Osteosarcoma (m/f/d)
Pflichtfelder sind mit einem (*) markiert.
karriere.klinikum.uni-heidelberg.de
May 14, 2025 at 11:39 AM
Reposted by Graeme Hewitt
📣Registration is now open for an exciting Gordon Conference on synthetic lethality organized by Ben Schwartz (GSK), Mathew Garnett (Sanger), and Francisca Vazquez (DepMap Director, Broad Institute)

Highly recommended!

Register here
grc.org/synthetic-le...
2025 Synthetic Lethality Approaches in Oncology Conference GRC
The 2025 Gordon Research Conference on Synthetic Lethality Approaches in Oncology will be held in Portland, Maine. Apply today to reserve your spot.
grc.org
January 29, 2025 at 8:05 PM
Reposted by Graeme Hewitt
New Gordon Research Conference Alert: Synthetic Lethality Approaches in Oncology. www.grc.org/synthetic-le....

Join us 20-25th July 2025 for an intimate meeting with thought leaders in the field. Great for networking and opportunities for early career scientists to present their research.
February 25, 2025 at 4:17 PM
Reposted by Graeme Hewitt
We have another PhD project at @qmbci.bsky.social, within @cruk-cityoflondon.bsky.social RadNET, to understand how POLE3 promotes Double Strand Break repair and resistance to radiotherapy ! get in touch if you are interested in a PhD in genome stability !
crukradnet.colcc.ac.uk/phd-students...
Investigating the role of POLE3 in resistance to ionizing radiation treatment - CRUK RadNet
Investigating the role of POLE3 in resistance to ionizing radiation treatment Primary supervisor: Roberto Bellelli, Queen Mary University of London Secondary supervisor: Graeme Hewitt, King’s College ...
crukradnet.colcc.ac.uk
February 21, 2025 at 9:43 AM
Reposted by Graeme Hewitt
Happy to share our review on the cellular responses to RNA damage 🥂

Congrats to joined first authors Jacqueline Cordes & @shubozhao.bsky.social

www.cell.com/cell/fulltex...
Cellular responses to RNA damage
RNA plays a central role in protein biosynthesis and performs diverse regulatory and catalytic functions, making it essential for all processes of life. Like DNA, RNA is constantly subjected to damage...
www.cell.com
February 20, 2025 at 6:37 PM
Reposted by Graeme Hewitt
1/Delighted to announce the newest paper from our lab, “Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage”, is out today in @naturecellbiology.bsky.social, www.nature.com/articles/s41....
Homologous recombination promotes non-immunogenic mitotic cell death upon DNA damage - Nature Cell Biology
Szmyd et al. show that DNA repair pathways impact whether cells with DNA lesions arrest in mitosis. The formation of homologous recombination-driven double Holliday junctions elicits mitotic cell deat...
www.nature.com
January 13, 2025 at 10:12 AM
Reposted by Graeme Hewitt
Our review on the recently discovered transcription-coupled DPC repair pathway is out in Trends in Cell Biology. Yet another wonderful collaboration with @cjcarnie.bsky.social and Steve Jackson.
Happy to share a review written with the wonderful @jstingele.bsky.social on transcription-coupled DPC repair, featuring an overview of new methods, close comparison with TC-NER, comments on clinical implications and plenty of discussion of the unknowns.

www.cell.com/trends/cell-...
Transcription-coupled repair of DNA–protein crosslinks
DNA–protein crosslinks (DPCs) are highly toxic DNA lesions that are relevant to multiple human diseases. They are caused by various endogenous and environmental agents, and from the actions of enzymes...
www.cell.com
December 2, 2024 at 7:51 AM
Reposted by Graeme Hewitt
Happy to share our latest work🍾 🥳

PhD student Sophie Dürauer discovered together with many wonderful collaborators that the ubiquitylation of DNA-protein crosslinks promotes their cleavage by SPRTN more than 100-fold 🧬🔧
November 28, 2024 at 6:18 PM